Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $116.7100 (-1.15%) ($112.9500 - $118.2300) on Mon. Jun. 6, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.94% (three month average) | RSI | 45 | Latest Price | $116.7100(-1.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1% a day on average for past five trading days. | Weekly Trend | LGND declines -0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) XBI(56%) IWO(55%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -0.97% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) GDXJ(-5%) IPO(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.97% (StdDev 1.94%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
Resistance Level | $119.19 | 5 Day Moving Average | $118.27(-1.32%) | 10 Day Moving Average | $119.79(-2.57%) | 20 Day Moving Average | $119.19(-2.08%) | To recent high | -10.5% | To recent low | 20.2% | Market Cap | $1.876b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |